Payment overview · 2025
General Payments
$53.17
3 reported records · 2 companies
Healthcare provider profile · identity verified
Jeffrey K Yates, DO
Allopathic & Osteopathic Physicians|Family Medicine · RUSSELLVILLE, AR · NPI 1932165024
Verified facts
What the public records show
CMS Open Payments records show Jeffrey K Yates, DO received $53.17 in general payments during 2025 across 3 reported records.
Novo Nordisk Inc accounted for 69.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance, Ozempic.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 37 claims for Jardiance by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 168 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $36.70 | 69.0% | 2 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $16.47 | 31.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $53.17 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $36.70 | 2 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $36.70 | 2 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Lilly USA, LLC | $16.47 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 37 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 168 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
37 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
168 | 25 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 472 | 95 |
| Gabapentin | Gabapentin | 412 | 76 |
| Losartan Potassium | Losartan Potassium | 358 | 81 |
| Pantoprazole Sodium | Pantoprazole Sodium | 331 | 70 |
| Atorvastatin Calcium | Atorvastatin Calcium | 313 | 82 |
| Omeprazole | Omeprazole | 313 | 72 |
| Tramadol Hcl | Tramadol Hcl | 305 | 63 |
| Amlodipine Besylate | Amlodipine Besylate | 282 | 76 |
| Metformin Hcl | Metformin Hcl | 250 | 57 |
| Metoprolol Succinate | Metoprolol Succinate | 237 | 55 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 231 | 54 |
| Tamsulosin Hcl | Tamsulosin Hcl | 221 | 49 |
| Duloxetine Hcl | Duloxetine Hcl | 213 | 42 |
| Potassium Chloride | Potassium Chloride | 190 | 49 |
| Escitalopram Oxalate | Escitalopram Oxalate | 185 | 38 |
| Meloxicam | Meloxicam | 182 | 42 |
| Furosemide | Furosemide | 181 | 45 |
| Zolpidem Tartrate | Zolpidem Tartrate | 179 | 27 |
| Benazepril Hcl | Benazepril Hcl | 169 | 45 |
| Trazodone Hcl | Trazodone Hcl | 169 | 39 |
| Ozempic | Semaglutide | 168 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 162 | 43 |
| Simvastatin | Simvastatin | 162 | 33 |
| Eliquis | Apixaban | 161 | 27 |
| Glimepiride | Glimepiride | 150 | 33 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 129 | 40 |
| Atenolol | Atenolol | 126 | 32 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 123 | 40 |
| Metoprolol Tartrate | Metoprolol Tartrate | 123 | 27 |
| Allopurinol | Allopurinol | 113 | 23 |
| Hydrochlorothiazide | Hydrochlorothiazide | 111 | 30 |
| Azithromycin | Azithromycin | 102 | 79 |
| Famotidine | Famotidine | 97 | 26 |
| Sertraline Hcl | Sertraline Hcl | 96 | 15 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 94 | 27 |
| Citalopram Hbr | Citalopram Hydrobromide | 91 | 16 |
| Carvedilol | Carvedilol | 86 | 17 |
| Prednisone | Prednisone | 82 | 57 |
| Montelukast Sodium | Montelukast Sodium | 81 | 17 |
| Clonazepam | Clonazepam | 80 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 80 | 21 |
| Celecoxib | Celecoxib | 79 | 20 |
| Farxiga | Dapagliflozin Propanediol | 78 | 15 |
| Alprazolam | Alprazolam | 77 | 17 |
| Januvia | Sitagliptin Phosphate | 75 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 74 | 22 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 71 | 17 |
| Lisinopril | Lisinopril | 65 | 17 |
| Finasteride | Finasteride | 64 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 61 | suppressed |
| Cefdinir | Cefdinir | 59 | 48 |
| Doxycycline Hyclate | Doxycycline Hyclate | 56 | 37 |
| Sucralfate | Sucralfate | 55 | 20 |
| Synthroid | Levothyroxine Sodium | 55 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 54 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 53 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 52 | 18 |
| Mirtazapine | Mirtazapine | 52 | 13 |
| Ezetimibe | Ezetimibe | 47 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 47 | suppressed |
| Glipizide Er | Glipizide | 47 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 46 | suppressed |
| Diazepam | Diazepam | 46 | suppressed |
| Lorazepam | Lorazepam | 46 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 46 | 25 |
| Levetiracetam | Levetiracetam | 45 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 44 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 42 | suppressed |
| Spironolactone | Spironolactone | 39 | 13 |
| Pregabalin | Pregabalin | 38 | suppressed |
| Jardiance | Empagliflozin | 37 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 36 | suppressed |
| Verapamil Er | Verapamil Hcl | 36 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 35 | 24 |
| Tresiba Flextouch U-100 | Insulin Degludec | 35 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 33 | suppressed |
| Aripiprazole | Aripiprazole | 33 | suppressed |
| Gemfibrozil | Gemfibrozil | 33 | suppressed |
| Olanzapine | Olanzapine | 33 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 32 | suppressed |
| Nateglinide | Nateglinide | 32 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 31 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 31 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 31 | 19 |
| Cephalexin | Cephalexin | 30 | 16 |
| Donepezil Hcl | Donepezil Hcl | 30 | suppressed |
| Naproxen | Naproxen | 30 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 30 | 23 |
| Diclofenac Sodium | Diclofenac Sodium | 29 | suppressed |
| Myrbetriq | Mirabegron | 29 | suppressed |
| Levofloxacin | Levofloxacin | 28 | 24 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 27 | suppressed |
| Estradiol | Estradiol | 27 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 27 | suppressed |
| Colchicine | Colchicine | 26 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 26 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 26 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 26 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 25 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 25 | suppressed |
| Linzess | Linaclotide | 25 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 25 | suppressed |
| Ramipril | Ramipril | 25 | suppressed |
| Topiramate | Topiramate | 25 | suppressed |
| Fluconazole | Fluconazole | 24 | 18 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 24 | suppressed |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 23 | suppressed |
| Lansoprazole | Lansoprazole | 23 | suppressed |
| Amoxicillin | Amoxicillin | 21 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 17 |
| Ondansetron Hcl | Ondansetron Hcl | 21 | 15 |
| Diclofenac Sodium Er | Diclofenac Sodium | 20 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 20 | suppressed |
| Irbesartan | Irbesartan | 20 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 20 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 20 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 20 | suppressed |
| Torsemide | Torsemide | 20 | suppressed |
| Baclofen | Baclofen | 19 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 19 | suppressed |
| Repaglinide | Repaglinide | 19 | suppressed |
| Sulindac | Sulindac | 19 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 18 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 18 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 18 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 18 | suppressed |
| Ketoconazole | Ketoconazole | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | 11 |
| Digoxin | Digoxin | 16 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 16 | suppressed |
| Glipizide | Glipizide | 16 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 16 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 16 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 16 | suppressed |
| Xarelto | Rivaroxaban | 16 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 15 | 13 |
| Colestipol Hcl | Colestipol Hcl | 15 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 15 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 15 | suppressed |
| Calcitriol | Calcitriol | 14 | suppressed |
| Indomethacin | Indomethacin | 14 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 13 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 13 | suppressed |
| Galantamine Er | Galantamine Hbr | 13 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 13 | suppressed |
| Memantine Hcl | Memantine Hcl | 13 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 13 | suppressed |
| Paliperidone Er | Paliperidone | 13 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 13 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 13 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 13 | 11 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 12 | suppressed |
| Euthyrox | Levothyroxine Sodium | 12 | suppressed |
| Fentanyl | Fentanyl | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Metolazone | Metolazone | 12 | suppressed |
| Metronidazole | Metronidazole | 12 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 12 | 12 |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 11 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 11 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Methotrexate | Methotrexate Sodium | 11 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Risperidone | Risperidone | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $53.17 · 3 records | Novo Nordisk Inc | JARDIANCE, Ozempic, Rybelsus | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error